Antonio Fabozzi

Dr. Antonio Fabozzi

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2024 in Sleep and Breathing
Verified
Journal Article
Open access
PDF file
Antonio FabozziAntonio Fabozzi
Antonio Fabozzi
FPFederico Pasqualotto
Federico Pasqualotto
MLMarianna Laguardia
Marianna Laguardia
PNPietro Francesco Natuzzi
Pietro Francesco Natuzzi
RCRosaria Capone
Rosaria Capone
PPPaolo Palange
Paolo Palange
Purpose: OSAS is a syndrome that often presents clinically differently between men and women. The aim of this study was to assess the clinical presentation, nocturnal home sleep cardiorespiratory monitoring and therapeutic adherence to CPAP in both sexes to identify the most frequent patterns. Methods: Data from the first visit, the nocturnal home sleep cardiorespiratory monitoring and follow-up visit of 74 OSA patients were collected. Exclusion criteria included other respiratory and/or neuromuscular diseases (including Obesity hypoventilation syndrome) and other non-respiratory sleep disorders. Results: Men were older and had a higher supine AHI and ODI compared to women. In addition, BMI and age correlated positively with AHI in males. Women had a higher hypopneas frequency and better therapeutic adherence to CPAP. Conclusions: Men were associated with a higher AHI when sleeping in the supine position and this may be useful to look for new therapeutic options in combination with or as an alternative to CPAP. BMI correlated positively with AHI in men and this should be considered to stimulate weight loss as the main treatment to reduce the number of apneas/hypopneas, as men also had less therapeutic adherence to CPAP in our study. Females presented a significantly higher frequency of hypopneas than men, as well as a lower number of desaturation events per hour (ODI): these differences in the nocturnal home sleep cardiorespiratory monitoring could reflect different pathophysiological mechanisms of OSAS onset between the two sexes, which should be investigated in future scientific studies.

5 September 2025 in Respiratory Medicine
Verified
Journal Article
Open access
Antonio FabozziAntonio Fabozzi
Antonio Fabozzi
Izolde BouloukakiIzolde Bouloukaki
Izolde Bouloukaki
MBMatteo Bonini
Matteo Bonini
SSSophia E. Schiza
Sophia E. Schiza
PPPaolo Palange
Paolo Palange
Asthma and obstructive sleep apnea (OSA) are two respiratory diseases that often may coexist, resulting in Alternative Overlap Syndrome (aOVS), which is still underestimated and underdiagnosed. This state-of-art review aims to describe the current evidence on aOVS, including its pathophysiology, clinical, functional and therapeutic implications. A secondary objective is to assess whether aOVS can be identified as a distinct endophenotype needing personalized diagnostic and therapeutic strategies. Asthma and OSA share several common risk factors, including obesity, gastroesophageal reflux disease (GERD) and rhinitis, which contribute to the pathogenesis of aOVS. From a pathophysiological perspective, aOVS has unique characteristics such as a low arousal threshold, nocturnal bronchial hyperresponsiveness and autonomic nervous system (ANS) dysfunction. These features lead to sleep fragmentation, altered ventilatory control, increased upper and lower airway resistance, and airway and systemic inflammation. From a functional perspective, patients with aOVS present lower FEV1 and increased nocturnal hypoxemia compared to subjects with only asthma or only OSA. From a clinical perspective, aOVS is linked to reduced asthma control, frequent exacerbations, and a lower quality of life. From a therapeutic perspective, continuous positive airway pressure (CPAP) has a positive impact on asthma control, symptom burden and inflammatory response. Weight loss, GERD and rhinitis management, and emerging therapies such as GLP-1 agonists and biological agents may provide additional benefit. Current evidence suggests that aOVS may be considered a distinct clinical endophenotype. Its identification is crucial to ensure timely diagnosis, improve management, and direct future research about long-term outcomes and personalized therapy.

17 October 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Antonio FabozziAntonio Fabozzi
Antonio Fabozzi
ASAlessia Steffanina
Alessia Steffanina
ANAmbra Nicolai
Ambra Nicolai
FOFederica Olmati
Federica Olmati
MBMatteo Bonini
Matteo Bonini
PPPaolo Palange
Paolo Palange
Background/Objectives: Obstructive sleep apnea (OSA) and obstructive lung diseases (OLD) are common and interdependent respiratory disorders, where one condition may contribute to the development and worsening of the other (OLDOSA syndrome). The term OLDOSA syndrome includes two different conditions: Overlap syndrome (OVS: OSA + chronic obstructive pulmonary disease, COPD) and Alternative Overlap syndrome (aOVS: OSA + Asthma). Data on the interactions between lung function and respiratory monitoring during sleep in OLDOSA patients are few and controversial. Our study aims to evaluate the impact of lung function impairment on sleep breathing disorders, paying attention to the lack of literature about comparisons between OVS, aOVS, and the impact of small airways disease (SAD) in these patients. Methods: In total, 101 patients with a diagnosis of OSA and asthma or COPD underwent pulmonary function tests (PFTs) and nocturnal home sleep cardiorespiratory monitoring (HSCM). Exclusion criteria: Obesity hypoventilation syndrome (OHS) and other non-respiratory sleep disorders. Results: Sleep time with oxygen saturation below 90% (T90) was negatively correlated with forced expiratory volume in the first second, % of predicted (%FEV1), forced vital capacity, % of predicted (%FVC), forced expiratory flow at 25–75% of the pulmonary volume, % of predicted (%FEF25–75), and, after multivariable linear regression analysis, %FEF25–75 remained an independent factor for T90 with a negative correlation in mild and moderate OSA. Obstructive apnea index (oAI) and FEV1/FVC were negatively correlated in mild and moderate OSA. OVS presented with more severe OSA (higher AHI, oAI, and T90) and SAD (lower FEF25–75) compared to aOVS. Conclusions: This study highlights a possible interdependence between OLD and OSA; obstruction of the large and small airways at PFTs contributes to the worsening of these patients’ nocturnal hypoxemia and obstructive events of the upper airway during sleep. Furthermore, this study shows that patients with OVS should be carefully monitored, as they present worse data at HSCM and have greater small airways involvement compared to aOVS.

10 February 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
Antonio FabozziAntonio Fabozzi
Antonio Fabozzi
ASAlessia Steffanina
Alessia Steffanina
MBMatteo Bonini
Matteo Bonini
PPPaolo Palange
Paolo Palange
Background: The high prevalence of obstructive sleep apnea (OSA), about 30% of people worldwide over 30 years old, underscores the crucial need for early screening. This study aimed to identify key predictive factors for OSA; use these factors to develop a screening equation for a population at high risk for OSA; and prospectively validate this equation’s application. Methods: The study included two phases: a retrospective phase examining anthropometric data, the Epworth sleepiness scale (ESS), and the home sleep apnea test (HSAT) from 200 patients referred to the Respiratory Sleep Disorder Center at Policlinico Umberto I, Rome, Italy (January 2020–January 2023) to create a predictive equation for OSA using multivariate analysis (with the most predictive data according to scientific literature). A prospective phase testing this equation on 53 patients from May 2023 to September 2024. Results: In the retrospective phase, the most predictive variables for the apnea–hypopnea index (AHI) identified were neck circumference (NC) and the Epworth sleepiness scale (ESS). The predictive equation derived from the multivariate analysis was as follows: AHIp = [−70.498 + (2.196 × NC) + (0.809 × ESS)]. In the prospective phase of the study, we compared the AHI predicted by the equation (AHIp) with the AHI measured via the HSAT (AHIm) in 53 patients recruited. The results showed that AHIp had a sensitivity of 95%, a specificity of 28%, a positive predictive value (PPV) of 46%, and a negative predictive value (NPV) of 90%. Conclusions: This study identified NC and ESS as key predictors of OSA, forming a predictive equation. This equation, showing high sensitivity and high NPV, may be useful as a screening method to rule out OSA.

31 December 2025 in Respiratory Medicine
Verified
Journal Article
Open access
GCGloria Maria Citton
Gloria Maria Citton
CAcaterina antonaglia
caterina antonaglia
Antonio FabozziAntonio Fabozzi
Antonio Fabozzi
ASAlessia Steffanina
Alessia Steffanina
SGSilvia Giannone
Silvia Giannone
MCMarco Confalonieri
Marco Confalonieri
Obstructive Sleep Apnea Syndrome (OSAS) is the most common sleep-related breathing disorder, considered more prevalent in males. Recent evidences suggest that prevalence of OSAS in females is underestimated, with a clinical phenotype marked by sleep fragmentation, poor sleep quality, and neurobehavioral symptoms. We hypothesized that a low arousal threshold (low AT) may be more common in females, which may underline these clinical and polysomnographic differences. In this retrospective multicentric study, 84 females and 93 males with OSA underwent a Home Sleep Apnea Test (HSAT) reviewed by a sleep expert. Low AT was predicted using the Edwards score criteria. Out of 177 patients, low AT was identified in 60.7 % of females and 40.9 % of males (p = 0.008). Stratifying by OSA severity, low AT was more prevalent in patients with mild disease, both in females and males. Among obese patients (Body Mass Index, BMI ≥30 kg/m2), low AT was present in 60.9 % of females compared to 24.3 % of males (p = 0.001). Our findings indicate that a low AT is significantly more prevalent in OSA females, remembering that our female population mainly corresponds to post-menopausal females. This may explain the more pronounced sleep fragmentation and neurobehavioral symptoms in women.

1 August 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
CAcaterina antonaglia
caterina antonaglia
Antonio FabozziAntonio Fabozzi
Antonio Fabozzi
ASAlessia Steffanina
Alessia Steffanina
SSSara Soave
Sara Soave
PCPaola Confalonieri
Paola Confalonieri
PPPaolo Palange
Paolo Palange
Background: Continuous positive airway pressure (CPAP) is the primary treatment for obstructive sleep apnea (OSA). Despite improvements in CPAP technology and management, adherence to therapy remains one of the main challenges to be addressed. Methods: We conducted a narrative review through PubMed (1995–2026). Studies were selected by clinical relevance, methodological quality and expert consensus. Results: OSA treatment outcomes are poor when CPAP adherence is defined as four hours per night. The first step in improving adherence is active patient involvement. This involves explaining what OSA is, its consequences, what PAP therapy is, and its potential benefits. The choice of the right mask is the first personalized step in CPAP adherence. OSA phenotype and endotype traits may help personalize treatment in selected patients, although their role in predicting CPAP adherence needs to be studied in greater depth. Problems during the first night and the first month are the main predictors of future adherence. Strategies such as cognitive behavioral therapy or motivational enhancement can improve adherence, especially during the initial period. Long-term adherence can be predicted from the initial period and maintained through scheduled follow-up. Group meetings, telephone calls and telemedicine interactions are also a valid way of improving adherence. Conclusions: Patients should initially be educated about how their symptoms are related to sleep apnea and how CPAP treatment could resolve them. The key to improving CPAP adherence is involving patients in personalized treatment with scheduled follow-up, particularly during the initial treatment period.